Health
AstraZeneca in talks to shift COVID-19 vaccine production to Catalent factory – NYT – Reuters
AstraZeneca Plc (AZN.L) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Baltimore plant to a factory owned by Catalent…
A vial labelled with the AstraZeneca coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File PhotoAstraZeneca Plc (AZN.L) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Baltimore plant to a factory owned by Catalent Inc (CTLT.N), the New York Times reported, citing people familiar with the matter.
The British drugmaker has been on the lookout for an alternative production…
-
General22 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General18 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business18 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General24 hours agoReview into WA’s e-bike, e-scooter laws finds ‘concerning’ lack of compliance from riders